1,391
Views
24
CrossRef citations to date
0
Altmetric
Breast cancer

Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines – a Swedish survey with central re-assessment

, , , , , , , & show all
Pages 1040-1048 | Received 20 Feb 2015, Accepted 26 Mar 2015, Published online: 11 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Anne-Vibeke Laenkholm, Dorthe Grabau, Maj-Lis Møller Talman, Eva Balslev, Anne Marie Bak Jylling, Tomasz Piotr Tabor, Morten Johansen, Anja Brügmann, Giedrius Lelkaitis, Tina Di Caterino, Henrik Mygind, Thomas Poulsen, Henrik Mertz, Gorm Søndergaard & Birgitte Bruun Rasmussen. (2018) An inter-observer Ki67 reproducibility study applying two different assessment methods: on behalf of the Danish Scientific Committee of Pathology, Danish breast cancer cooperative group (DBCG). Acta Oncologica 57:1, pages 83-89.
Read now

Articles from other publishers (23)

Torsten O Nielsen, Samuel C Y Leung, Nazia Riaz, Anna M Mulligan, Zuzana Kos, Anita Bane & Timothy J Whelan. (2023) Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trial. Histopathology 83:6, pages 903-911.
Crossref
Kåre Nielsen, Michael Sode, Maj-Britt Jensen, Tobias Berg, Ann Knoop, Bent Ejlertsen & Anne-Vibeke Lænkholm. (2023) High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patients. Breast Cancer Research 25:1.
Crossref
Balazs Acs, Samuel C.Y. Leung, Kelley M. Kidwell, Indu Arun, Renaldas Augulis, Sunil S. Badve, Yalai Bai, Anita L. Bane, John M.S. Bartlett, Jane Bayani, Gilbert Bigras, Annika Blank, Henk Buikema, Martin C. Chang, Robin L. Dietz, Andrew Dodson, Susan Fineberg, Cornelia M. Focke, Dongxia Gao, Allen M. Gown, Carolina Gutierrez, Johan Hartman, Zuzana Kos, Anne-Vibeke Lænkholm, Arvydas Laurinavicius, Richard M. Levenson, Rustin Mahboubi-Ardakani, Mauro G. Mastropasqua, Sharon Nofech-Mozes, C. Kent Osborne, Frédérique M. Penault-Llorca, Tammy Piper, Mary Anne Quintayo, Tilman T. Rau, Stefan Reinhard, Stephanie Robertson, Roberto Salgado, Tomoharu Sugie, Bert van der Vegt, Giuseppe Viale, Lila A. Zabaglo, Daniel F. Hayes, Mitch Dowsett, Torsten O. Nielsen, David L. Rimm, Mitch Dowsett, Daniel F. Hayes, Lisa M. McShane, Kelley M. Kidwell, Torsten Nielsen, Samuel Leung, Balazs Acs, Indu Arun, Renaldas Augulis, Sunil S. Badve, Yalai Bai, Anita L. Bane, John M.S. Bartlett, Jane Bayani, Gilbert Bigras, Annika Blank, Signe Borgquist, Henk Buikema, Angela Chan, Martin C. Chang, Carsten Denkert, Robin L. Dietz, Andrew Dodson, Anna Ehinger, Matthew Ellis, Susan Fineberg, Margaret Flowers, Cornelia M. Focke, Chad Galderisi, Dongxia Gao, Abhi Gholap, Allen M. Gown, Carolina Gutierrez, Douglas J. Hartman, Johan Hartman, Judith C. Hugh, Anagha Jadhav, Elizabeth N. Kornaga, Zuzana Kos, Hans Kreipe, Anne-Vibeke Lænkholm, Arvydas Laurinavicius, Richard Levenson, Mauro Mastropasqua, Takuya Moriya, Sharon Nofech-Mozes, C. Kent Osborne, Hongchao Pan, Liron Pantanowitz, Ernesta Paola Neri, Frédérique M. Penault-Llorca, Mei-Yin Polley, Tammy Piper, Mary Anne Quintayo, Tilman T. Rau, David L. Rimm, Stefan Reinhard, Stephanie Robertson, Jason Ruan, Takashi Sakatani, Roberto Salgado, Lois Shepherd, Ian Smith, Joseph Sparano, Melanie Spears, Malini Srinivasan, Jane Starczynski, Tomoharu Sugie, Austin Todd, Bert van der Vegt, Giuseppe Viale, Shakeel Virk, Yihong Wang, Hua Yang, Lila A. Zabaglo, Zhiwei Zhang & Inti Zlobec. (2022) Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study. Modern Pathology 35:10, pages 1362-1369.
Crossref
Zohair Selmani, Chloé Molimard, Alexis Overs, Fernando Bazan, Loic Chaigneau, Erion Dobi, Nathalie Meneveau, Laura Mansi, Marie-Justine Paillard, Guillaume Meynard, Julien Viot, Marie-Paule Algros, Christophe Borg, Jean-Paul Feugeas, Xavier Pivot, Jean-Luc Prétet & Elsa Curtit. (2022) Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry. Scientific Reports 12:1.
Crossref
Jahnavi Kalvala, Ruth M Parks, Andrew R Green & Kwok‐Leung Cheung. (2021) Concordance between core needle biopsy and surgical excision specimens for Ki‐67 in breast cancer – a systematic review of the literature. Histopathology 80:3, pages 468-484.
Crossref
Kimberly H. Allison. 2022. A Comprehensive Guide to Core Needle Biopsies of the Breast. A Comprehensive Guide to Core Needle Biopsies of the Breast 873 894 .
Anna C S Bodén, Jesper Molin, Stina Garvin, Rebecca A West, Claes Lundström & Darren Treanor. (2021) The human‐in‐the‐loop: an evaluation of pathologists’ interaction with artificial intelligence in clinical practice. Histopathology 79:2, pages 210-218.
Crossref
Torsten O Nielsen, Samuel C. Y Leung, David L Rimm, Andrew Dodson, Balazs Acs, Sunil Badve, Carsten Denkert, Matthew J Ellis, Susan Fineberg, Margaret Flowers, Hans H Kreipe, Anne-Vibeke Laenkholm, Hongchao Pan, Frédérique M Penault-Llorca, Mei-Yin Polley, Roberto Salgado, Ian E Smith, Tomoharu Sugie, John M. S Bartlett, Lisa M McShane, Mitch Dowsett & Daniel F Hayes. (2021) Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group. JNCI: Journal of the National Cancer Institute 113:7, pages 808-819.
Crossref
Balazs Acs, Irma Fredriksson, Caroline Rönnlund, Catharina Hagerling, Anna Ehinger, Anikó Kovács, Rasmus Røge, Jonas Bergh & Johan Hartman. (2021) Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based Study. Cancers 13:5, pages 1166.
Crossref
Suzanne Parry, Mitch Dowsett & Andrew Dodson. (2021) UK NEQAS ICC & ISH Ki-67 Data Reveal Differences in Performance of Primary Antibody Clones. Applied Immunohistochemistry & Molecular Morphology 29:2, pages 86-94.
Crossref
Emma Sandén, Somayeh Khazaei, Helga Tryggvadottir, Signe Borgquist, Karolin Isaksson, Karin Jirström & Helena Jernström. (2020) Re-evaluation of HER2 status in 606 breast cancers—gene protein assay on tissue microarrays versus routine pathological assessment. Virchows Archiv 477:2, pages 317-320.
Crossref
Christine Lundgren, Pär-Ola Bendahl, Åke Borg, Anna Ehinger, Cecilia Hegardt, Christer Larsson, Niklas Loman, Martin Malmberg, Helena Olofsson, Lao H. Saal, Tobias Sjöblom, Henrik Lindman, Marie Klintman, Jari Häkkinen, Johan Vallon-Christersson, Mårten Fernö, Lisa Rydén & Maria Ekholm. (2019) Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer. Breast Cancer Research and Treatment 178:2, pages 459-467.
Crossref
Samuel C Y Leung, Torsten O Nielsen, Lila A Zabaglo, Indu Arun, Sunil S Badve, Anita L Bane, John M S Bartlett, Signe Borgquist, Martin C Chang, Andrew Dodson, Anna Ehinger, Susan Fineberg, Cornelia M Focke, Dongxia Gao, Allen M Gown, Carolina Gutierrez, Judith C Hugh, Zuzana Kos, Anne‐Vibeke Lænkholm, Mauro G. Mastropasqua, Takuya Moriya, Sharon Nofech‐Mozes, C Kent Osborne, Frédérique M Penault‐Llorca, Tammy Piper, Takashi Sakatani, Roberto Salgado, Jane Starczynski, Tomoharu Sugie, Bert van der Vegt, Giuseppe Viale, Daniel F Hayes, Lisa M McShane & Mitch Dowsett. (2019) Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration. Histopathology 75:2, pages 225-235.
Crossref
M. Ekholm, P.O. Bendahl, M. Fernö, B. Nordenskjöld, O. Stål & L. Rydén. (2019) Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial. European Journal of Cancer 110, pages 53-61.
Crossref
Christian BruefferJohan Vallon-Christersson, Dorthe GrabauAnna EhingerJari HäkkinenCecilia HegardtJanne MalinaYilun ChenPär-Ola BendahlJonas ManjerMartin MalmbergChrister LarssonNiklas Loman, Lisa RydénÅke BorgLao H. Saal. (2018) Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative. JCO Precision Oncology:2, pages 1-18.
Crossref
Huina Zhang, Min Han, Kavita R. Varma, Beth Z. Clark, Rohit Bhargava & David J. Dabbs. (2018) High Fidelity of Breast Biomarker Metrics: A 10-Year Experience in a Single, Large Academic Institution. Applied Immunohistochemistry & Molecular Morphology 26:10, pages 697-700.
Crossref
Paula Cabrera-Galeana, Wendy Muñoz-Montaño, Fernando Lara-Medina, Alberto Alvarado-Miranda, Victor Pérez-Sánchez, Cynthia Villarreal-Garza, R. Marisol Quintero, Fany Porras-Reyes, Enrique Bargallo-Rocha, Ignacio Del Carmen, Alejandro Mohar & Oscar Arrieta. (2018) Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy. The Oncologist 23:6, pages 670-678.
Crossref
Julia van Steenhoven, Anne Kuijer, Paul van Diest, Joost van Gorp, Marieke Straver, Sjoerd Elias, Jelle Wesseling, Emiel Rutgers, Johanna Timmer-Bonte, Peter Nieboer, Tineke Smilde, Alex Imholz, Charlotte Blanken, Sabine Siesling & Thijs van Dalen. (2018) Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study. Genes 9:5, pages 261.
Crossref
Cornelia M. Focke, Horst Bürger, Paul J. van Diest, Kai Finsterbusch, Doreen Gläser, Eberhard Korsching, Thomas Decker, M. Anders, R. Bollmann, Fr. Eiting, K. Friedrich, J.-O. Habeck, G. Haroske, B. Hinrichs, A. Behrens, U. Krause, U. Lang, J. Lorenzen, N. Minew, M. Mlynek-Kersjes, H. Nenning, J. Packeisen, F. Poche-de Vos, S. Reyher–Klein, D. Rothacker, M. Schultz, U. Sturm, M. Tawfik, K.-H. Berghäuser, W. Böcker, G. Cserni, S. Habedank, S. Lax, F. Moinfar, P. Regitnig, A. Reiner-Concin, J. Rüschoff, Z. Varga & J. Woziwodski. (2017) Interlaboratory variability of Ki67 staining in breast cancer. European Journal of Cancer 84, pages 219-227.
Crossref
Cornelia M. Focke, Paul J. van Diest & Thomas Decker. (2016) St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods. Breast Cancer Research and Treatment 159:2, pages 257-263.
Crossref
Antroula Papakonstantinou, Theodoros Foukakis, Kenny A. Rodriguez-Wallberg & Jonas Bergh. (2016) Is Estradiol Monitoring Necessary in Women Receiving Ovarian Suppression for Breast Cancer?. Journal of Clinical Oncology 34:14, pages 1573-1579.
Crossref
. (2016) A 21-Gene Expression Assay in Breast Cancer. New England Journal of Medicine 374:14, pages 1385-1387.
Crossref
Kristin C. Jensen & Kimberly H. Allison. 2016. A Comprehensive Guide to Core Needle Biopsies of the Breast. A Comprehensive Guide to Core Needle Biopsies of the Breast 785 802 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.